89894-44-0

Basic information

• Product Name: Benzoyl chloride, 2-chloro-6-methyl- (9CI)
• Synonyms: Benzoyl chloride, 2-chloro-6-methyl- (9CI);2-Chloro-6-methylbenzoyl Chloride
• CAS NO: 89894-44-0
• Molecular Formula: C₈H₆Cl₂O
• Molecular Weight: 189.03864
• Product Categories: ACIDHALIDE
• Mol File: 89894-44-0.mol
• Article Data: 18

Chemical Properties

• Boiling Point: 114-116 °C(Press: 16 Torr)
• Appearance: /
• Density: 1.312±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Benzoyl chloride, 2-chloro-6-methyl- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoyl chloride, 2-chloro-6-methyl- (9CI)(89894-44-0)
• EPA Substance Registry System: Benzoyl chloride, 2-chloro-6-methyl- (9CI)(89894-44-0)

Safety Data

• Hazardous Substances Data: 89894-44-0(Hazardous Substances Data)

Usage

General Description

Benzoyl chloride, 2-chloro-6-methyl- (9CI) is a chemical compound with the molecular formula C8H7ClO. It is a colorless to pale yellow liquid with a strong, suffocating odor. Benzoyl chloride, 2-chloro-6-methyl- (9CI) is primarily used in the production of agrochemicals, pharmaceuticals, and dyes, as well as in the synthesis of other organic compounds. Benzoyl chloride, 2-chloro-6-methyl- (9CI) is a versatile intermediate in the chemical industry and is also used as a reagent in organic synthesis. It is important to handle this compound with care as it is highly corrosive and can cause skin, eye, and respiratory irritation.

Upstream product

• 21327-86-6 2-chloro-6-methylbenzoic acid 
• 6575-09-3 2-chloro-6-methyl-benzonitrile 
• 101080-58-4 2-chloro-6-methylbenzamide 
• 87-63-8 2-chloro-6-methylaniline 
• 118-91-2 ortho-chlorobenzoic acid 
• 5100-98-1 1-chloro-2-iodo-3-methylbenzene 
• 99585-14-5 methyl 2-chloro-6-methylbenzoate 
• 69190-56-3 2-bromo-1-chloro-3-methylbenzene 
• 85070-46-8 2-chloro-6-methylbenzenediazonium tetrafluoroborate 
• 387-45-1 2-chloro-6-fluorobenzaldehyde 
• 1194-64-5 2-chloro-6-methylbenzaldehyde 

Downstream Products

• 99585-14-5 methyl 2-chloro-6-methylbenzoate 
• 343851-24-1 N-[(2-chloro-6-methylphenyl)carbonyl]-4-(1,3,6-trimethyl-2,4-dioxo-5-pyrimidinyl)-L-phenylalanine 1-(acetoxy)ethyl ester 
• 343981-42-0 N-[(2-chloro-6-methylphenyl)carbonyl]-4-(1,4-dimethyl-6-(trifluoromethyl)-2-oxo-3-pyridinyl)-L-phenylalanine 
• 343851-20-7 N-[(2-chloro-6-methylphenyl)carbonyl]-4-(1,3,6-trimethyl-2,4-dioxo-5-pyrimidinyl)-L-phenylalanine 2-(4-morpholino)ethyl ester 
• 261732-13-2 (S) 3-[1-(2-chloro-benzoyl)-1,2,3,4-tetrahydro-quinolin-6-yl]-2-(2-chloro-6-methyl-benzoylamino)-propionic acid 
• 261732-14-3 (S) 3-{1-[(3-chloro-4-hydroxy-phenyl)-acetyl]-1,2,3,4-tetrahydro-quinolin-6-yl}-2-(2-chloro-6-methyl-benzoylamino)-propionic acid 
• 220847-10-9 N-[(2-Chloro-6-methylphenyl)carbonyl]-4-nitro-L-phenylalanine methyl ester 
• 1420829-86-2 C₂₃H₁₇ClN₄OS 
• 1420829-90-8 C₂₆H₁₉N₇OS 
• 1420830-49-4 (S)-8-chloro-3-(1-(2-chloro-3-nitropyridine-4-ylamino)ethyl)-2-phenylisoquinolin-1(2H)-one 
• 1420830-50-7 C₂₂H₁₇ClN₄O₃S 
• 1420830-51-8 C₂₂H₁₉ClN₄OS 
• 1420830-03-0 C₂₇H₂₁N₇OS 
• 1420829-02-2 C₂₂H₁₆ClN₅OS 

Relevant articles and documents

COMPOUNDS, COMPOSITIONALS, AND METHODS FOR TREATING T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

In an aspect, the disclosure provides for compounds (II), compositions, and methods of administering the compounds and compositions to a patient in need thereof. In another aspect, the disclosure relates to compounds and compositions for treating cancer,

Pyrimido oxazine derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for use in preventing or treating PI3 kinase related diseases

The present invention relates to pyrimido oxazine derivatives or pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition comprising the same as an effective component for preventing or treating PI3 kinase-related diseases. The pyrimido oxazine derivatives according to the present invention have excellent selective inhibitory effects on PI3 kinase, and thus may be beneficially used in preventing or treating PI3 kinase-related diseases such as the following: cancers including blood cancer, ovarian cancer, cervical cancer, breast cancer, large intestine cancer, liver cancer, stomach cancer, pancreatic cancer, colon cancer, periotoneal cancer, skin cancer, bladder cancer, prostate cancer, lung cancer, osteosarcoma, fibrous tumor, and brain tumor; autoimmune diseases including rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, type 1 diabetes, hyperthyroidism, myasthenia gravis, Crohnandprime;s disease, ankylosing spondylitis, psoriasis, pernicious anemia, and Sjogrenandprime;s syndrome; and respiratory diseases including chronic obstructive pulmonary disease (COPD), rhinitis, asthma, chronic bronchitis, chronic pulmonary inflammatory diseases, silicosis, pulmonary sarcoidosis, pleuritis, alveolitis, vasculitis, emphysema, pneumonia, and bronchiectasis.COPYRIGHT KIPO 2017

QUINAZOLINE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

The present invention provides a quinazoline derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same and a use thereof. The quinazoline derivative or its pharmaceutically acceptable salt has a selective inhibitory activity against the phosphatidylinositol 3-kinase delta subunit, and therefore can be usefully applied for preventing or treating cancer, along with avoiding side effects such as lymphopenia-associated inflammatory responses.